Home
About SinovacProductsPipelineInvestorsContact Us
 
 
  SITEMAP 中文版
  Pipeline
R&D Strategy
Japanese Encephalitis Vaccine
Pandemic Influenza Vaccine (H5N1)
SARS Vaccine
Home Page
 
Influenza vaccine is one of the few with very high growing demand. This market has been acknowledged as a market with the highest growth rate. Government recommendation of using influenza vaccine is a key driver of the growth of influenza vaccine demand.

In China, influenza vaccine demand and supply are balanced. However, as the population keeps growing, more and more people become aware of healthcare, and especially after the outbreak of SARS in China, the attention about influenza prevention became unprecedented running up. Therefore, influenza vaccine market is very promising.
Copyright © 2001-2008 Sinovac Biotech Ltd. All rights reserved.